Figure 2.

Participant disposition.
Ih group: study participants receiving DTPa‑HBV‑IPV/Hib vaccine; Va group: study participants receiving DTaP5‑HB‑IPV‑Hib vaccine
N, number of participants with available results; PPS: per protocol set, includes all study participants who received all study vaccinations and complied with all study-related interventions and conditions as defined in the study protocol.